NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, ...
Credit: Getty Images. The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions. Certain factors should be considered when ...
On Monday, the FDA approved Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) supplemental New Drug Application (sNDA) for its Acetadote (N-acetylcysteine for injection) product. Acetadote is an ...
FDA approved a simplified Acetadote dosing regimen, reducing errors and serious reactions while maintaining effectiveness. Acetadote addresses liver injury from acetaminophen toxicity, the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results